Page 62 - Programme book for The International Liver Congress 2015, EASL ILC 2015

THURSDAY, APRIL 23, 2015

Joint Workshop: EASL-KASL Lehar 1 & 2

SCIENTIFIC PROGRAMME Chairs:
Laurent Castera, France
Kwang-Hyub Han, South Korea

12:00-12:15 Risk of hepatocellular carcinoma in chronic hepatitis B:
12:15-12:30 assessment and modification with current antiviral therapy
12:30-12:45 George Papatheodoridis, Greece
12:45- 13:00
13:00-13:15 HBV-related hepatocellular carcinoma prediction models in
13:15-13:30 the era of antiviral therapy
Beom Kyung Kim, South Korea

Italica cohort: curative Tx in BCLC B patients
Anna Pecorelli, Italy

On- and off-treatment efficacy of antiviral prophylaxis in
hepatitis B carrier undergoing cancer chemotherapy
Jihyun An, South Korea

Adeno-asssociated virus 2 (AAV2) induces recurrent
insertional mutagenesis in Human hepatocellular carcinomas
Jean-Charles Nault, France

Biomarkers reflecting tumour biology of hepatocellular
carcinoma
Su Jong Yu, South Korea

62 The International Liver Congress™ 2015 • ILC Programme